- Retraction Note
- Open Access
Retraction Note: Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer
World Journal of Surgical Oncology volume 17, Article number: 119 (2019)
The original article was published in World Journal of Surgical Oncology 2016 14:224
Retraction Note: World J Surg Oncol
None of the authors have responded to any correspondence from the editor or publisher about this retraction.
Su K, Zhang T, Wang Y, Hao G. Diagnostic and prognostic value of plasma microRNA-195 in patients with non-small cell lung cancer. World J Surg Oncol. 2016;14:224 https://doi.org/10.1186/s12957-016-0980-8.
Zhu DY, Li XN, Qi Y, Liu DL, Yang Y, Zhao J, Zhang CY, Wu K, Zhao S. MiR-454 promotes the progression of human non-small cell lung cancer and directly targets PTEN. Biomed Pharmacother. 2016;81:79–85.
Li RZ, Wang LM. RETRACTED ARTICLE: Decreased microRNA-452 expression and its prognostic significance in human osteosarcoma. World J Surg Oncol. 2016;14:150. https://doi.org/10.1186/s12957-016-0900-y.
Komatsu S, Ichikawa D, Tsujiura M, Konishi H, Takeshita H, Nagata H, Kawaguchi T, Hirajima S, Arita T, Shiozaki A, Kubota T, Fujiwara H, Okamoto K, Otsuji E. Prognostic impact of circulating miR-21 in the plasma of patients with gastric carcinoma. Anticancer Res. 2013;33:271–6 http://ar.iiarjournals.org/content/33/1/271.full.pdf.
Zhang KC, Xi HQ, Cui JX, Shen WS, Li JY, Wei B, Chen L. Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis. Am J Cancer Res. 2015;5(2):821–9 http://www.ajcr.us/files/ajcr0003875.pdf.